CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −3,304.56 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −11,316.26 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −1,672.39 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −210.15 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −436.07 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −2,837.05 | 0 | ||
| 2024-04-08 | Singer Michael Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −2,837.05 | 0 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise | +491,853 | 506,377 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise | +2,926,764 | 3,036,887 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −14,755.61 | 0 | ||
| 2024-04-08 | Kalayoglu Murat Director | Option exercise · Series A Non-Voting Convertible Preferred Stock | −87,802.95 | 101,953.44 | ||
| 2024-04-08 | SPRINGER TIMOTHY A Director | Option exercise | −123,925.41 | 0 | ||
| 2024-04-08 | SPRINGER TIMOTHY A Director | Option exercise | +4,130,846 | 4,379,899 | ||
| 2024-04-08 | SPRINGER TIMOTHY A Director | Option exercise | −24,785.08 | 0 | ||
| 2024-04-08 | SPRINGER TIMOTHY A Director | Option exercise | +826,169 | 1,927,630 | ||
| 2024-04-08 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,276.45 | 0 | ||
| 2024-04-08 | Jewell Christopher M Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | +142,547 | 142,547 | ||
| 2024-04-08 | Miljkovic Milos Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,565.87 | 0 | ||
| 2024-04-08 | Miljkovic Milos Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | +85,528 | 85,528 | ||
| 2024-04-08 | Kurtoglu Metin Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −6,414.68 | 0 |
Page 11 of 16 · 316 trades